protoporphyrin ix has been researched along with Barrett Epithelium in 23 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
Excerpt | Relevance | Reference |
---|---|---|
"Surveillance of patients with Barrett's esophagus or ulcerative colitis for dysplasia is confined to biopsy specimens taken randomly during endoscopy because dysplasia remains undetectable by visual inspection." | 5.30 | Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. ( Bäumler, W; Holstege, A; Knüchel, R; Messmann, H; Schölmerich, J, 1999) |
" The aim of this study was to establish the optimum dosage regime for ALA-PDT for Barrett's esophagus." | 2.71 | Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Brown, SB; Kelty, CJ; Reed, MW, 2004) |
"Barrett's esophagus has been identified as the premalignant precursor of esophageal adenocarcinoma." | 2.41 | Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. ( Barr, H, 2000) |
"Preliminary studies in early esophageal cancer also show effectiveness." | 2.41 | Photodynamic therapy for esophageal cancer. Update. ( Greenwald, BD, 2000) |
"Barrett's esophagus is strongly associated with adenocarcinoma." | 1.32 | Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid. ( Dorta, G; Felley, C; Fontolliet, C; Gabrecht, T; Grosjean, P; Jornod, P; Lange, N; Monnier, P; Stepinac, T; van den Bergh, H; vanMelle, G; Wagnières, G, 2003) |
"Surveillance of patients with Barrett's esophagus or ulcerative colitis for dysplasia is confined to biopsy specimens taken randomly during endoscopy because dysplasia remains undetectable by visual inspection." | 1.30 | Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. ( Bäumler, W; Holstege, A; Knüchel, R; Messmann, H; Schölmerich, J, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (30.43) | 18.2507 |
2000's | 13 (56.52) | 29.6817 |
2010's | 3 (13.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yeh, SC | 2 |
Ling, CS | 1 |
Andrews, DW | 2 |
Patterson, MS | 2 |
Diamond, KR | 1 |
Hayward, JE | 1 |
Armstrong, D | 2 |
Fang, Q | 2 |
Sahli, S | 1 |
Provias, J | 1 |
Holz, JA | 1 |
Boerwinkel, DF | 1 |
Meijer, SL | 1 |
Visser, M | 1 |
van Leeuwen, TG | 1 |
Bergman, JJ | 1 |
Aalders, MC | 1 |
Hinnen, P | 4 |
de Rooij, FW | 4 |
Hop, WC | 1 |
Edixhoven, A | 4 |
van Dekken, H | 2 |
Wilson, JH | 4 |
Siersema, PD | 5 |
Brand, S | 1 |
Wang, TD | 1 |
Schomacker, KT | 1 |
Poneros, JM | 1 |
Lauwers, GY | 1 |
Compton, CC | 1 |
Pedrosa, MC | 1 |
Nishioka, NS | 1 |
Ortner, MA | 1 |
Ebert, B | 1 |
Hein, E | 1 |
Zumbusch, K | 1 |
Nolte, D | 1 |
Sukowski, U | 1 |
Weber-Eibel, J | 1 |
Fleige, B | 1 |
Dietel, M | 1 |
Stolte, M | 1 |
Oberhuber, G | 1 |
Porschen, R | 1 |
Klump, B | 1 |
Hörtnagl, H | 1 |
Lochs, H | 2 |
Rinneberg, H | 1 |
Stepinac, T | 1 |
Felley, C | 1 |
Jornod, P | 1 |
Lange, N | 1 |
Gabrecht, T | 1 |
Fontolliet, C | 1 |
Grosjean, P | 1 |
vanMelle, G | 1 |
van den Bergh, H | 1 |
Monnier, P | 1 |
Wagnières, G | 1 |
Dorta, G | 1 |
Kelty, CJ | 1 |
Ackroyd, R | 2 |
Brown, NJ | 1 |
Brown, SB | 1 |
Reed, MW | 1 |
Barr, H | 2 |
Shepherd, NA | 1 |
Dix, A | 1 |
Roberts, DJ | 1 |
Tan, WC | 1 |
Krasner, N | 1 |
Vonarx, V | 1 |
Eleouet, S | 1 |
Carre, J | 1 |
Ioss, P | 1 |
Gouyette, A | 1 |
Leray, AM | 1 |
Merle, C | 1 |
Lajat, Y | 2 |
Patrice, T | 2 |
Ortner, M | 1 |
Messmann, H | 2 |
Knüchel, R | 2 |
Endlicher, E | 1 |
Hauser, T | 1 |
Szeimies, RM | 1 |
Kullmann, F | 1 |
Bäumler, W | 2 |
Schölmerich, J | 2 |
van Velthuysen, ML | 1 |
van Hillegersberg, R | 3 |
Tilanus, HW | 2 |
Holstege, A | 1 |
Brown, N | 1 |
Vernon, D | 1 |
Roberts, D | 1 |
Stephenson, T | 1 |
Marcus, S | 1 |
Stoddard, C | 1 |
Reed, M | 1 |
Wang, KK | 1 |
Terlouw, EM | 1 |
Greenwald, BD | 1 |
van den Boogert, J | 1 |
van Staveren, HJ | 1 |
de Bruin, RW | 1 |
Bourre, L | 1 |
Thibaut, S | 1 |
Briffaud, A | 1 |
Pech, O | 1 |
Nagy, CD | 1 |
Gossner, L | 1 |
May, A | 1 |
Ell, C | 1 |
3 reviews available for protoporphyrin ix and Barrett Epithelium
Article | Year |
---|---|
Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Humans; Injections, Intravenous; Intestinal M | 2000 |
Photodynamic therapy of Barrett's esophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Fiber Optic Technology; Hematoporphyrin Deriv | 2000 |
Photodynamic therapy for esophageal cancer. Update.
Topics: Animals; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasms; Humans; Photochemotherapy | 2000 |
3 trials available for protoporphyrin ix and Barrett Epithelium
Article | Year |
---|---|
Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Endoscopy; Female | 2002 |
Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Cohort | 2004 |
5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Topics: Aminolevulinic Acid; Barrett Esophagus; Humans; Photochemotherapy; Photosensitizing Agents; Protopor | 1999 |
17 other studies available for protoporphyrin ix and Barrett Epithelium
Article | Year |
---|---|
5-aminolevulinic acid for quantitative seek-and-treat of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Aminolevulinic Acid; Barrett Esophagus; Cell Line, Tumor; Cell Survival; Humans; Intracellular Space | 2015 |
5-Aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Adenocarcinoma; Algorithms; Aminolevulinic Acid; Barrett Esophagus; Biomarkers; Esophageal Neoplasms | 2015 |
Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membrane.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Biopsy; Chickens; Chorioallantoic Membrane; Humans; | 2016 |
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esopha | 2002 |
Time gated fluorescence spectroscopy in Barrett's oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Biomarkers, | 2003 |
Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Topics: Aminolevulinic Acid; Barrett Esophagus; Cell Line, Transformed; Cells, Cultured; Ferrochelatase; Hum | 2002 |
Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Carcinoma in Situ; Esopha | 2003 |
Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Humans; Male; Middle Aged; Photoche | 1996 |
Potential efficacy of a delta 5-aminolevulinic acid bioadhesive gel formulation for the photodynamic treatment of lesions of the gastrointestinal tract in mice.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Biocompatible Materials; Disease Models, Animal; Fi | 1997 |
[Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Fe | 1998 |
[Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].
Topics: Adenoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colorectal Neopla | 1998 |
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Topics: Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Female; Ferroc | 1998 |
Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Topics: Adenomatous Polyps; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Colitis, Ulcerative | 1999 |
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett E | 2000 |
Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Esophagus; Male; Photochemotherapy; Protoporphyrins | 2001 |
Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Drug Stability; Gastric Mucosa; Gels; Male; Mice; M | 2002 |
Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Barrett Esophagus; Esophageal Neoplasms; Humans; Mice; | 2002 |